<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20111210008359N3</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-09-05</date_registration>
      <primary_sponsor>Tabriz University of Medical Sciences</primary_sponsor>
      <public_title>The effect of scheduled visit of family caregivers on incidence and severity of delirium among patients admitted in ICU and their caregivers anxiety</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the Effectiveness of Scheduled Visits of Family Caregivers on incidence and severity of Delirium among Patients admitted to ICU and their caregivers' anxiety</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-09-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>40</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/72171</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: The participants will be 40 male and female conscious patients hospitalized in Intensive care units and will be selected through convenience sampling. At the beginning of each work shift, the researcher will be informed about the availability of beds and the possible admission of new patients by visiting in person or by calling the officials of the special departments. The participants in the groups will be assigned to the intervention and control groups using the random block method with 4 and 6 blocks and with a ratio of 1:1. Stratification will be done based on the sampling location (Imam Reza, Sinai and Razi Hospital). In order to hide the allocation, the type of allocation will be written on paper and placed in opaque envelopes that are numbered consecutively (Allocation Concealment). The envelopes will be opened in order and by a person not involved in sampling. If the participant is included in the intervention group, a member of the patient's family who meets the family caregiver entry criteria will be selected as the patient's main caregiver to participate in the intervention. Then, the communication protocol and meeting schedule will be taught face-to-face and in writing to the family caregivers of the intervention group.</study_design>
      <phase>N/A</phase>
      <hc_freetext>delirium.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: After determining the main caregiver, the objectives and method of the study are explained to them. Then, in a briefing session, the necessary training is provided regarding how to perform the intervention, and then the materials are given to them in the form of a booklet. After the coordination of the researcher with the patient's nurse and the shift manager, the family caregivers of the patients are present at the patient's bedside for 15 minutes from 16:00 to 17:00 and from 21:00 to 22:00 and communicate with the patient according to the defined protocol. During the entire duration of the meeting, the researcher is a non-participant observer of the meeting and examines the caregiver's performance during the meeting. If necessary, after the completion of the intervention, training will be given to the caregiver again so that the method of implementing the intervention can be modified in the next meeting. Also, before the presence of the caregiver at the patient's bedside, immediately after leaving the patient's bedside, 60, 120, and 180 minutes after the presence of the caregiver, the patient is checked with the NeeCham scale in terms of the incidence and severity of delirium. Intervention 2: Control group: meeting in this group is done according to routine meetings. The researcher was present at the patient's bedside at the appointed time for the visit and immediately before and after the presence of the caregiver, 60, 120 and 180 minutes after the presence of the caregiver, as in the intervention group, examines the patient with the NeeCham scale in terms of the incidence and severity of delirium. .</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Farnaz Rrahmani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Sought shariate street, Tabriz nursing and midwifery school, Tabriz University of Medical Sciences, Tabriz, Iran</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5138947977</zip>
        <telephone>+98 41 1479 6770</telephone>
        <email>frahmani@tbzmed.ac.ir</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Farnaz Rrahmani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Sought shariate street, Tabriz nursing and midwifery school, Tabriz University of Medical Sciencesو, Tabriz, Iran</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5138947977</zip>
        <telephone>+98 41 3479 6770</telephone>
        <email>frahmani@tbzmed.ac.ir</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Conscious patients with Glasgow Coma Index score &lt;13
Willingness and consent to participate in the study
Patients who are not completely isolated
No delirium and cognitive disorders in the patient before entering the study
Not taking anti-anxiety drugs at the time of starting the intervention by the caregiver</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>80 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Unavailability of primary caregiver</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F05</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Delirium due to known physiological condition</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>N/A</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: After determining the main caregiver, the objectives and method of the study are explained to them. Then, in a briefing session, the necessary training is provided regarding how to perform the intervention, and then the materials are given to them in the form of a booklet. After the coordination of the researcher with the patient's nurse and the shift manager, the family caregivers of the patients are present at the patient's bedside for 15 minutes from 16:00 to 17:00 and from 21:00 to 22:00 and communicate with the patient according to the defined protocol. During the entire duration of the meeting, the researcher is a non-participant observer of the meeting and examines the caregiver's performance during the meeting. If necessary, after the completion of the intervention, training will be given to the caregiver again so that the method of implementing the intervention can be modified in the next meeting. Also, before the presence of the caregiver at the patient's bedside, immediately after leaving the patient's bedside, 60, 120, and 180 minutes after the presence of the caregiver, the patient is checked with the NeeCham scale in terms of the incidence and severity of delirium.</i_keyword>
      <i_keyword>Control group: meeting in this group is done according to routine meetings. The researcher was present at the patient's bedside at the appointed time for the visit and immediately before and after the presence of the caregiver, 60, 120 and 180 minutes after the presence of the caregiver, as in the intervention group, examines the patient with the NeeCham scale in terms of the incidence and severity of delirium. .</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Incidence and severity of Delirium. Timepoint: Before the intervention, 60, 120 and 180 minutes after the intervention for 5 consecutive days. Method of measurement: The Neelon and Champagne Confusion Scale(NeeCham).</prim_outcome>
      <prim_outcome>Anxiety score of the main caregiver. Timepoint: The first day before the intervention, the fifth day after the intervention. Method of measurement: Speilberger State – Trait Anxiety Inventory (STAI).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tabriz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-08-07</approval_date>
        <contact_name>Ethics Committee of Tabriz University of Medical Sciences, Vice chancellor for research</contact_name>
        <contact_address>Sought shariatee street, Tabriz nursing and midwifery school, Tabriz University of Medical Sciences Tabriz East Azarbaijan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
